Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,005 public trials 1,217 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Personalized Radiation Therapy for GBM

NCT03477513

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver

NCT03472586

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma

NCT06153238

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Sandoz Investigational Site Orange, California, United States

Sandoz Investigational Site Clermont, Florida, United States

Sandoz Investigational Site Orange City, Florida, United States

Sandoz Investigational Site Banja Luka, Bosnia and Herzegovina

View all 61 locations

View Trial Details

Completed

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

NCT04609566

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations: Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States

Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States

Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States

Highlands Oncology Group, PA Fayetteville, Arkansas, United States

View all 90 locations

View Trial Details

Completed

RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma

NCT00113360

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +17 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab

NCT04401995

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)

NCT05698199

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

NCT02576431

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +43 more
Locations: Stanford Cancer Center Palo Alto Palo Alto, California, United States

UCLA Health Santa Monica Cancer Care Santa Monica, California, United States

Memorial Cancer Institute at West Pembroke Pines, Florida, United States

The University of Chicago Medical Center - Hyde Park - Hematology & Oncology Chicago, Illinois, United States

View all 98 locations

View Trial Details

Completed

Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor

NCT03239145

Conditions: Adnexal Diseases, Advanced Solid Tumor, Colonic Diseases, +37 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

FIH Clinical Investigation of Graphene Electrodes for Brain Mapping

NCT06368310

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumor, +13 more
Locations: Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust Salford, Greater Manchester, United Kingdom

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions